drugset / Trial / NCT00254774

Efficacy and Safety of Quetiapine Compared With Valproate in the Treatment of Patients With Bipolar Disorder and Rapid Cycling

NCT00254774

Phase 3 Completed 44 enrolled AstraZeneca
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of the study is to evaluate the efficacy of quetiapine compared to valproate during a 12 month treatment period in subjects with Bipolar Disorder I or II with Rapid Cycling.

Timeline

Start
2002-01
Primary completion
Completion
2006-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Quetiapine Small molecule
Subject Valproate Small molecule

Indications